Latest Articles

European Stock Markets Narrowly Mixed

European Stock Markets Narrowly Mixed

The Spanish IBEX is outperforming as markets buy into dips and start to discount Catalan secession risks, although the situation remains volatile. The DAX is moving sideways at very high levels, with strong production data at the start of the session not sufficient to push the index above the 13000 mark for the first time. The Euro Stoxx 50 is […]

October 11, 2017 ×
Little Movement for Tech Stocks Monday

Little Movement for Tech Stocks Monday

Technology stocks have turned slightly higher again this afternoon, reversing a small decline earlier and shares of tech companies in the S&P 500 advancing nearly 0.1%. In company news, CounterPath Corp (CPAH,PATH.TO) was holding at its Monday session high in U.S. trade of $2.59 a share, rising over 11%, after the Canadian voice over internet protocol networking company today said […]

October 4, 2017 ×
Health Care Stocks Extending Market-Leading Gains

Health Care Stocks Extending Market-Leading Gains

Health care stocks were sharply higher today, with the NYSE Health Care Index rising over 0.8% while shares of health care companies in the S&P 500 also were up more than 0.8% as a group. In company news, Alphatec Holdings (ATEC) advanced over 46% on Monday, climbing to a session high of $3.30 a share after the medical device company […]

October 4, 2017 ×
US Treasuries End With Curves Mildly Mixed

US Treasuries End With Curves Mildly Mixed

Treasuries prices opened a touch lower/curves a bit steeper but ended about where they started, though curves were mildly mixed. Attendance was light given week-long holidays in multiple Asian nations including China, which celebrates National Day during the Oct. 1-6 period. It too was a somber day after a mass shooting in Las Vegas last night killed more than 50 […]

October 4, 2017 ×
Neos Therapeutics Launches ADHD Drug Cotempla XR-ODT in the U.S.

Neos Therapeutics Launches ADHD Drug Cotempla XR-ODT in the U.S.

Neos Therapeutics (NEOS) fell marginally in Monday’s afternoon trade after the pharmaceutical company said it has launched Cotempla XR-ODT in the United States. Commercially available in select markets since September 2017, Cotempla XR-ODT is the first and only methylphenidate extended-release orally disintegrating tablet for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 to 17 years old. The […]

October 4, 2017 ×